Drugs / T-DXd
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07117864 | Jul 2025 → Jul 2026 overdue | breast cancer | QIAO LI | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-DXd | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07117864 ↗ |
| Route | Intravenous | “T-DXd：5.4mg/kg ivgtt Q3w SRT/WBRT” NCT07117864 ↗ |